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Acidosis and growth in nonuremic renal disease
ELISABETH MCSHERRY
Departments of Pediatrics and Medicine, University of California at San Francisco, San Francisco, California
Chronic metabolic acidosis is commonly associ-
ated with significantly impaired growth in children
with kidney disease. In children with diffuse renal
disease, chronic acidosis and growth impairment,
other factors, e.g., osteodystrophy, uremia and ma!-
nutrition, as described elsewhere in this issue.
may contribute to impaired growth. The question of
whether acidosis alone affects growth in children
with renal disease has long been considered. We re-
cently have shown that children with an isolated
disorder of renal acidification, type 1 RTA, after
prolonged acidosis have short stature; sustained
correction of acidosis restores stature to normal.
Whether acidosis directly impairs growth in these
patients or does so through secondary effects of hy-
povolemia, potassium deficiency, and disturbances
in calcium metabolism is not known. This report re-
views the evidence relating acidosis to growth im-
pairment in children with isolated renal disorders.
As a direct extension of these results, the question
arises whether correction of acidosis benefits
growth in nonuremic children with more general-
ized renal disease; that question, through careful
clinical evaluations, is yet to be answered.
Acidosis alone, a cause of growth impairment?
In patients with nonuremic renal disease with-
out persisting hypophosphatemia, chronic hyper-
chloremic metabolic acidosis is associated with sig-
nificantly impaired growth, stunting (defined as
height less than —2.5 SD from the mean for age- and
sex-matched normal children) [1—191. Stunting oc-
curs in patients with a) classic, type 1 renal tubular
acidosis(RTA)[1, 2,4,5, 7—19],b) adisorderdiag-
nosed as isolated proximal RTA (without the Fan-
coni syndrome) [111, and c) nonuremic chronic re-
nal disease, not primarily identified by disordered
renal acidification [31. In West and Smith's study of
41 children with nonuremic chronic renal disease (at
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least 19 of whom had mild to moderate azotemia),
metabolic acidosis was present in 16 of the 21 chil-
dren who had significant growth impairment but
was absent in all children who did not [31. In signifi-
cantly growth impaired infants and children with
RTA, correction of chronic acidosis with alkali
therapy alone can be accompanied by immediate in-
crease in height velocity [1,2, 9—111. Four formerly
stunted patients with the disorder diagnosed as
transient isolated proximal RTA were shown to at-
tain normal height after long-term alkali therapy
[11]; it is not clear, however, whether renal acid-
ification remained disordered at the time normal
stature was achieved [11].
Effect of conventional alkali therapy ( 3 mEqlkg/day) on
acidosis in children with type / RTA
In children with persisting type 1 RTA, signifi-
cant growth impairment has persisted or occurred
despite administration of alkali in low doses (3
mEq/kg/day or less) [7, 13] (see Table 1). In infants
and children with apparent type 1 RTA described in
the older literature, several times this amount of al-
kali failed to correct the acidosis [20—241. In infants
with documented type I RTA, renal bicarbonate-
wasting (defined as the urinary excretion of net base
in amounts  3 mEq/kg/day at normal or subnormal
plasma bicarbonate concentrations) occurred
[25—27] and dictated an amount of alkali therapy
greater than 3 mEq/kg/day [14, 15,25—271 (see Table
2). We reasoned that in children also with type 1
RTA, acidosis might persist despite the provision of
alkali in doses of 1 to 3 mEq/kglday, and that per-
sisting acidosis might be critical to the causation of
growth impairment.
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Table 1. Stunting in children with type I RTA that persisted or
occurred despite low-dose alkali therapy
Alkali therapy
Age span Maximum dose
yr inEqlkglday
I —5.7 13—14.5 0.8
4 —2.6 7—16 2.5
7 —5.0 0.6_4.Oa 2.7
10 —3.4 12.8—17.8 2.3
II <2.5 13—18 1—3
13 —3.5 0.02._4.5a 2.5
a Stunting occurred in these two patients despite low-dose
alkali therapy.
In 10 patients with persistent type I RTA, we in-
vestigated 1) growth before and after alkali therapy,
2) the amount of alkali needed to correct acidosis,
and 3) the factors that determined the alkali require-
ment. Correction of acidosis was considered sus-
tained if the early morning, fasting, arterialized
plasma bicarbonate concentration, prior to the ad-
ministration of alkali therapy, was between 19 and
22 mEq/Iiter in infants and 23 and 28 mEq/liter in
children. In all of the patients. the dose of alkali
therapy required to sustain correction of acidosis
exceeded 3 mEq/kg/day at some time [15].
Before alkali therapy, six patients were stunted;
their mean height was —3.3 SD [14, 15, 281 (Fig. 1,
Table 2. Renal bicarbonate-wasting in infants with type I RTA.
necessitating high-dose alkali therapy
Alkali therapy
Fig. 1. The effect of alkali therapy on height in /0 children with
type / RTA. Height is expressed in percentiles relative to age-
matched and sex-matched populations. "Standard" reference
populations for patients, and for unaffected parents of patients
with familial RTA, are from Reed and Stuart (Pediatrics 24:904,
1959). "Tanner" values for patients' height potential (predicted
from mean parental height) ("alter") are from Tanner, Gold-
stein. and Whitehouse [29]. Limits of the lightly shaded area =
2.5 so from the mean: the darker area = so. Solid horizon-
tal lines the mean for the group: dashed horizontal lint's
median. (Reprinted with permission of the,! Cliii !,nest [15]).
McSherry [25], 1972 6.5 0.02—2 (8)"
4.4 0.38-10 10
Leumann [271, 1975 [5,11 0,12—3.50 4,5,(6)
Soriano [26], 1975 [13.7]
[5.61
15.4]
0,08—1.83
0.16—2.0
0.83
l0'
10"
5
McSherry [IS], 1978 7.5
6.3
5.4
3.1
0,02—7(1
t).12—lO
0.83—7.0
0.21—10
14.0
9.0
12.6
7.8
a In each patient, the value for urinary excretion of net base
(Unet hae'1), (in controlled metabolic studies) or as indicated by
the brackets. CHCO3—/C,,, (during acute bicarbonate infusions)
was the mean of at least three measurements, when [HCO,1p
and GFR were normal.
Numbers in parentheses indicate that the dose was not con-
sistently administered.
This dose of alkali was maintained 1 yr before the dose was
lowered to 7.5 mEq/kg/day: in all other patients receiving > 5
mEq/kglday the large doses were maintained at least 2 and in
so/ne cases up to 6 yr.
This dose was lowered to 3—4.5 mEq/kglday after less than I
month,
far left panel). Four patients were small but not yet
stunted. Two of these were neonates, too young for
growth to have become significantly impaired, and
two had been shown earlier to he nonacidotic. The
heights attained relative to age-matched and sex-
matched normals correlated inversely with the max-
imal possible duration of acidosis. The maximal
possible duration of acidosis was considered to be
the lifetime of the patient from birth until date of
diagnosis, except when acidosis had been shown
not to he present at previous times, in which case
the maximal possible duration of acidosis was esti-
mated as the time between the last date of demon-
strating nonacidosis and the date of diagnosis. In
each patient, height velocity was diminished (Fig.
2).
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Fig. 2. The effect of alkali therapy on linear growth velocities in 8
patients with type 1 RTA: (a) 5 postneonatal infants, (length),
and (h)3prepuhertal children (height). Each symbol denotes the
midpoint of the observation period; the crossbars denote the lim-
its of the period. Open symbols denote the linear growth veloci-
ties during chronic acidosis, immediately before the start of al-
kali therapy; closed symbols denote the velocities immediately
after sustained correction of acidosis with alkali therapy. Curve
represents the mean value derived from data for normal female
infants (Watson and Lowry, Growth and Development of Chil-
dren, Yearbook Medical Publishers, 1969, pp. 87—88) (panel a),
or normal male children 1291 (panel b).
Effects ofsustained correction acidosis with high-dose
alkali in children with type I RTA
Immediately after alkali therapy, height velocity
increased two- to threefold in each of the 10 patients
(Fig. 2) and persisted at values greater than the
mean for age-matched and sex-matched normal
children until normal stature was attained. The av-
erage height was at the 37th percentile for com-
parable normal children (Figs. I and 3) and was not
significantly different from normal. The heights of
all affected children reached the normal range (± 2
SD) and were distributed normally: 4 of the 10 chil-
dren were at the 50th percentile or greater. By con-
trast, the mean height of the 10 parent pairs was
significantly less than that of the normal population
Fig.. 3. Infit'e infants with type 1 RTA, stunting (in four), or im-
paired growth (in one), immediately before alkali therapy (open
symbols), was corrected in / yr (closed symbols) with sustained
correction of acidosis. The limits of the heavily and lightly shaded
enclosed areas indicate I and 2.5 SD, respectively, of the
mean stature for normal female infants 0 to 18 months. "Grid" is
the Columbia University adaptation (Kaplan and Grumbach)
from data of Reed and Stuart (Pediatrics 24:904, 1959).
(P < 0.05). When analyzed by the Tanner tech-
nique, which takes into account the influence of
midparental height, the mean height of the eight pa-
tients (in the analyzable age range) was at the 69th
percentile. In those children in whom alkali therapy
was started after 10 months of age, height after sus-
tained correction of acidosis correlated inversely
with the duration of acidosis before the onset of al-
kali therapy. In those children in whom alkali thera-
py was started before 6 months of age, the height
achieved was unrelated to the duration of preceding
acidosis. With correction of acidosis, muscle-wast-
ing, emaciation, grey pallor, listlessness, anorexia,
vomiting, constipation, lethargy, and poor school
performance disappeared (Table 3).
Evidence that renal bicarbonate-wasting increases alkali
requirement in children with type I RTA
At some time in the course of treatment of each of
the 10 patients, the amount of alkali required to sus-
tain correction of acidosis exceeded 5 mEq/kg/day(range 5 to 14 mEq/kglday). In 8 patients, the
requirement for alkali initially was less than 3
14
8
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TabIe 3. Clinical findings at diagnosis in infants and children with persistent type I RTA
Patient Age at
Symptoms and signs
Poor5 Grey5 Growth
groupa Sex diagnosis Feeding Vomiting pallor impairment
IV-8 M 3.5 yr + 0 — Stunted
IV-1l F 6wk + + + Stunted
lV-10 M 2.5 yr + 0 + Stunted
IV-13 F 10 mo + 0 0 Diminished
JV-15 F lOday + 0 + Newborn
111-1 F 2 yr + 0 0 Diminished
ID-i F 4 mo + + + Stunted
ID-2 F 2.5 mo + + + Stunted
ID-3 F 4.5 mo + + + Stunted
LD-4 F 3 day + + + Newborn
a Patients IV-8, 10, 11, 13, 15 were members of same generation of the same kindred Family A (Annals Intern Med 54: 110, 1961).
Patient tlI-1 was a member of third generation of Family B (cf, Ref. 15). ID-I, 2. 3, 4 were patients judged to have idiopathic RTA.
b Poor feeding indicates lack of vigor in feeding, not necessarily diminished caloric intake. Grey pallor refers to the appearance of the
face, lips, and distal extremities.
mEq/kglday, but increased to higher values over the
first 3 to 6 months (in infants) or 1 to 2 yr (in chil-
dren). In nine patients during sustained correction
of acidosis with large doses of alkali, renal bicarbo-
nate-wasting was the major determinant of the al-
kali therapeutic requirement; in most cases, the
sum of the net base excretion and an assumed en-
dogenous acid production of 2 to 3 mEq/kg/day
closely approximated the amount of alkali required.
It seems unlikely that the renal bicarbonate-wasting
in these children was the consequence of over-
expansion of extracellular volume, since blood and
plasma volumes were normal, and values of 24-hr
urinary aldosterone excretion and plasma renin ac-
tivity were normal or elevated [15, 28]. Additional-
ly, mild acidosis was documented (in six patients) to
occur and to persist despite the administration of
amounts of alkali documented earlier to correct the
acidosis: from 4.2 to 10.0 mEq/kg/day. During aci-
dosis, the sum of the net base excretion and an as-
sumed endogenous production of nonvolatile acid
of 2 to 3 mEq/kg/day closely approximated the
amount of alkali administered.
The results of our study indicate that sustained
correction of acidosis in children with type I RTA
will require alkali therapy in excess of 5
mEq/kg/day at some time; and with sustained cor-
rection, children will attain normal stature. Renal
bicarbonate-wasting is the major determinant of the
amount of alkali therapy required in these children.
A priori, it could not have been predicted that in
this study of 10 children with type I RTA, each
would attain normal height percentiles with alkali
therapy [14, 15, 281. Given only the results of the
single other published systematic study of growth in
children with type 1 RTA, one might have con-
cluded that growth was limited by pathogenetic fac-
tors other than those responsive to alkali therapy
[Ill. Since type 1 RTA can be an expression of a
number of disease processes [30, 31], it could have
been inferred that in those affected children who re-
main stunted after alkali therapy, the disease proc-
ess, not acidosis, was limiting with respect to
growth. Yet, it is clear from our study that metabol-
ic acidosis (with its metabolic consequences) was
the overriding determinant of impaired growth, re-
gardless of whether the disorder of renal acid-
ification was idiopathic or a familial, genetically
transmitted trait.
Acidosis may cause growth impairment in other clinical
conditions
Chronic hyperchloremic metabolic acidosis itself
may impair growth. Growth impairment attends
the hyperchloremic acidosis that occurs in prema-
ture infants on high-protein feeds (protein  2.5
glkg/day), and it is reported to reverse when dietary
protein content is lowered or alkali therapy is added
[32—35]. Tobler and Prader 36] and Prader, Tanner,
and von Harnack [131 reported hyperchioremic
acidosis and growth retardation in 19 of 22 children
with ureterosigmoidostomies. In the one of four pa-
tients in whom correction of acidosis was sustained,
height velocity increased immediately after starting
alkali [36]. It is not clear, however, that normal
height was attained by any of the four patients
[36, 37]. Bergstrom reported that stunting did not
occur in one of two children with ureterosigmoid-
ostomy and chronic acidosis, but data on the kind
and severity of the acidosis were not given for
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either patient [6]. Normal stature has been ob-
served in individual patients with persisting renal
acidification defects and hyperchloremic acidosis
[2, 11, 12, 381, but on the basis of the data reported,
the duration and severity of the hyperchloremic
acidosis are not clear. Rats made acidotic with am-
monium chloride had profound growth impairment
[39]; impaired growth, however, was not demon-
strated in rats made acidotic with 0.4% acetazola-
mide alone. Since the weight of these rats and their
pair-fed controls was 50% that of the same-aged rats
in each of the other experimental groups at the initia-
tion of the study, this does not conclusively demon-
strate that rats with chronic hyperchloremic aci-
dosis grow normally.
Summary
Our data demonstrate that correction of acidosis
is sustained in children with type 1 RTA when alkali
therapy is given in doses of 5 to 14 mEq/kg/day. The
large doses are required as a result of renal bicarbo-
nate-wasting. Children with type 1 RTA and aci-
dosis who have significant growth impairment expe-
rience catch-up growth and attain normal stature for
their age when correction of acidosis is sustained.
Whether chronic acidosis impairs growth in any clin-
ical condition except type 1 RTA is not settled.
Whether sustained correction of acidosis with alkali
therapy will allow attainment of normal stature in
children with nonuremic diffuse renal disease is not
yet determined. With the increasing availability of
microchemistry and microgasometry and the new
standards for growth based on mean-parent height
[40], it can be anticipated that answers to these
clinically important questions will be forthcoming.
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